Comprehensive Review of AL amyloidosis: some practical recommendations - Centre René Gauducheau Accéder directement au contenu
Article Dans Une Revue Blood Cancer Journal Année : 2021

Comprehensive Review of AL amyloidosis: some practical recommendations

Résumé

Amyloid light chain (AL) amyloidosis is among the more common and more severe of the amyloidoses usually involving the slow proliferation of a bone-marrow-residing plasma cell (PC) clone and the secretion of unstable immunoglobulin-free light chains (FLC) that infiltrate peripheral tissues and result in detrimental end-organ damage. Disease presentation is rather vague, and the hallmark of treatment is early diagnosis before irreversible end-organ damage. Once diagnosed, treatment decision is transplant-driven whereby ~20% of patients are eligible for autologous stem cell transplantation (ASCT) with or without bortezomib-based induction. In the setting of ASCT-ineligibility, bortezomib plays a central role in upfront treatment with the recent addition of daratumumab to the current emerging standard of care. In general, management of AL amyloidosis is aimed at achieving deep, durable responses with very close monitoring for early detection of relapse/refractory disease. This article provides a comprehensive review of the management of patients with AL amyloidosis including goals of therapy, current treatment guidelines in the setting of both ASCT-eligibility and ineligibility, treatment response monitoring recommendations, toxicity management, and treatment of relapse/refractory disease.

Mots clés

Fichier principal
Vignette du fichier
s41408-021-00486-4.pdf (3.2 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03231102 , version 1 (20-05-2021)

Identifiants

Citer

Rama Al Hamed, Abdul Hamid Bazarbachi, Ali Bazarbachi, Florent Malard, Jean-Luc Harousseau, et al.. Comprehensive Review of AL amyloidosis: some practical recommendations. Blood Cancer Journal, 2021, 11 (5), pp.97. ⟨10.1038/s41408-021-00486-4⟩. ⟨hal-03231102⟩
89 Consultations
49 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More